Lyra Therapeutics Stock Price Prediction
| LYRA Stock | USD 0.21 0.02 10.53% |
Oversold Vs Overbought
27
Oversold | Overbought |
EPS Estimate Next Quarter (0.21) | EPS Estimate Current Year (1.27) | EPS Estimate Next Year (0.94) | Wall Street Target Price 1.25 | EPS Estimate Current Quarter (0.23) |
Using Lyra Therapeutics hype-based prediction, you can estimate the value of Lyra Therapeutics from the perspective of Lyra Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Lyra Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Lyra because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Lyra Therapeutics after-hype prediction price | USD 0.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Lyra |
Lyra Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Lyra Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lyra Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lyra Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lyra Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Lyra Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lyra Therapeutics' historical news coverage. Lyra Therapeutics' after-hype downside and upside margins for the prediction period are 0.01 and 6.76, respectively. We have considered Lyra Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lyra Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Lyra Therapeutics is based on 3 months time horizon.
Lyra Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Lyra Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lyra Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lyra Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.33 | 6.55 | 0.00 | 0.07 | 4 Events / Month | 10 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.21 | 0.21 | 0.00 |
|
Lyra Therapeutics Hype Timeline
Lyra Therapeutics is now traded for 0.21. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.07. Lyra is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at -0.33%. %. The volatility of related hype on Lyra Therapeutics is about 3011.49%, with the expected price after the next announcement by competition of 0.14. About 60.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.66. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lyra Therapeutics has Price/Earnings To Growth (PEG) ratio of 1.61. The entity recorded a loss per share of 1.49. The firm had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 4 days. Check out Lyra Therapeutics Basic Forecasting Models to cross-verify your projections.Lyra Therapeutics Related Hype Analysis
Having access to credible news sources related to Lyra Therapeutics' direct competition is more important than ever and may enhance your ability to predict Lyra Therapeutics' future price movements. Getting to know how Lyra Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lyra Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CTMX | CytomX Therapeutics | (0.06) | 9 per month | 0.00 | (0.06) | 6.25 | (5.22) | 20.61 | |
| ASMB | Assembly Biosciences | (0.19) | 7 per month | 4.39 | (0.01) | 8.79 | (5.34) | 21.34 | |
| ACHL | Achilles Therapeutics PLC | (0.03) | 4 per month | 1.39 | 0.13 | 3.06 | (2.78) | 38.16 | |
| NLTX | Neoleukin Therapeutics | (1.12) | 4 per month | 0.00 | (0.08) | 4.05 | (3.53) | 27.84 | |
| TIL | Instil Bio | (1.12) | 8 per month | 6.97 | 0.13 | 20.63 | (10.89) | 105.83 | |
| NXTC | NextCure | (0.04) | 5 per month | 0.00 | (0.15) | 5.22 | (6.37) | 21.68 | |
| SPRO | Spero Therapeutics | (0.01) | 9 per month | 0.00 | (0.15) | 3.79 | (4.58) | 14.92 | |
| NUVB | Nuvation Bio | 0.21 | 8 per month | 0.00 | (0.04) | 9.48 | (8.36) | 21.30 | |
| CGEM | Cullinan Oncology LLC | (0.23) | 9 per month | 0.00 | (0.16) | 5.88 | (7.24) | 17.85 | |
| BOLT | Bolt Biotherapeutics | 0.01 | 7 per month | 0.00 | (0.09) | 4.84 | (4.48) | 14.96 | |
| DAWN | Day One Biopharmaceuticals | 0.27 | 10 per month | 2.77 | (0.05) | 3.84 | (3.69) | 11.44 | |
| AUTL | Autolus Therapeutics | (0.30) | 8 per month | 0.00 | (0.06) | 6.49 | (7.83) | 26.03 |
Lyra Therapeutics Additional Predictive Modules
Most predictive techniques to examine Lyra price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lyra using various technical indicators. When you analyze Lyra charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Lyra Therapeutics Predictive Indicators
The successful prediction of Lyra Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lyra Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lyra Therapeutics based on analysis of Lyra Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lyra Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lyra Therapeutics's related companies. | 2023 | 2024 (projected) | Graham Number | 7.13 | 14.15 | Receivables Turnover | 6.7 | 5.96 |
Story Coverage note for Lyra Therapeutics
The number of cover stories for Lyra Therapeutics depends on current market conditions and Lyra Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lyra Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lyra Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Lyra Therapeutics Short Properties
Lyra Therapeutics' future price predictability will typically decrease when Lyra Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lyra Therapeutics often depends not only on the future outlook of the potential Lyra Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lyra Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 49.8 M | |
| Cash And Short Term Investments | 102.8 M |
Complementary Tools for Lyra Stock analysis
When running Lyra Therapeutics' price analysis, check to measure Lyra Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lyra Therapeutics is operating at the current time. Most of Lyra Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lyra Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lyra Therapeutics' price. Additionally, you may evaluate how the addition of Lyra Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |